Drug
Leo 43204
Leo 43204: highest development phase Phase 3, developed by LEO Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- LEO Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| LEO 43204 gel NCT02549339 | Phase 3 | Actinic Keratosis |
Latest
No recent events.
Follow Leo 43204 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.